SOPHiA GENETICS Past Earnings Performance

Past criteria checks 0/6

SOPHiA GENETICS's earnings have been declining at an average annual rate of -13.6%, while the Healthcare Services industry saw earnings growing at 6.8% annually. Revenues have been growing at an average rate of 21.3% per year.

Key information

-13.6%

Earnings growth rate

-3.6%

EPS growth rate

Healthcare Services Industry Growth7.9%
Revenue growth rate21.3%
Return on equity-55.0%
Net Margin-102.8%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How SOPHiA GENETICS makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:90B Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2465-677836
31 Mar 2464-738237
31 Dec 2362-798237
30 Sep 2359-697934
30 Jun 2354-788035
31 Mar 2351-828235
31 Dec 2248-878435
30 Sep 2245-958735
30 Jun 2244-938632
31 Mar 2242-867930
31 Dec 2140-747027
30 Sep 2137-636025
30 Jun 2134-524923
31 Mar 2130-414120
31 Dec 2028-393619
31 Dec 1925-343515

Quality Earnings: 90B is currently unprofitable.

Growing Profit Margin: 90B is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 90B is unprofitable, and losses have increased over the past 5 years at a rate of 13.6% per year.

Accelerating Growth: Unable to compare 90B's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 90B is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (17%).


Return on Equity

High ROE: 90B has a negative Return on Equity (-54.99%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies